Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer
This study has been completed.
Southwest Oncology Group
Information provided by:
National Cancer Institute (NCI)
First received: June 6, 2001
Last updated: June 20, 2013
Last verified: January 2008
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2006|
|Estimated Primary Completion Date:||No date given|
Van Veldhuizen PJ, Faulkner JR, Lara PN Jr, Gumerlock PH, Goodwin JW, Dakhil SR, Gross HM, Flanigan RC, Crawford ED; Southwest Oncology Group. A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109. Cancer Chemother Pharmacol. 2005 Jul;56(1):39-45. Epub 2005 Mar 25.